TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
15 hedge funds and large institutions have $1.24M invested in Titan Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
42% less funds holding
Funds holding: 26 → 15 (-11)
91% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 11
Holders
15
Holding in Top 10
–
Calls
$624K
Puts
$184K
Top Buyers
| 1 | +$195K | |
| 2 | +$47K | |
| 3 | +$11.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.62K |
| 5 |
Morgan Stanley
New York
|
+$5K |
Top Sellers
| 1 | -$58K | |
| 2 | -$53K | |
| 3 | -$18K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
| 5 |
WPA
Winning Points Advisors
Boca Raton,
Florida
|
-$11.5K |